FIELD: medicine. SUBSTANCE: method involves obtaining selenium-containing glycoprotein element-organic substance possessing immunostimulating activity. The substances have low molecular mass component like protein, selenium, carbohydrate residue and various inorganic ions introducible with aqueous solutions like calcium, strontium, iron, magnesium cations and cyanide, hydrophosphate, dihydro-orthosilicate, iodide anions. EFFECT: enhanced effectiveness of treatment; increased CD4 T-helper cells production; increased killer and phagocytic activity. 4 cl, 8 dwg
Authors
Dates
2001-12-20—Published
2001-01-22—Filed